Background
==========

Many antiepileptic drugs are targeting GABAergic synaptic transmission, but may cause certain side effects \[[@B1],[@B2]\]. GABA~A~ receptors (GABA~A~-Rs) are abundant not only at synaptic sites, but also at extrasynaptic sites. Synaptic GABA~A~-Rs have low affinity for GABA, are activated in a transient manner by GABA released form presynaptic vesicles, and primarily mediate phasic inhibitory transmission. In contrast, extrasynaptic GABA~A~-Rs exhibit high affinity for GABA, are persistently activated by low concentration of ambient GABA, and mediate tonic inhibition \[[@B3]-[@B5]\]. There are two distinct subtypes of extrasynaptic GABA~A~-Rs in the brain, one contains the α5 subunit \[[@B6]-[@B10]\] and the other contains the δ subunit \[[@B11]-[@B13]\]. The α5-GABA~A~-Rs are sensitive to a specific inverse agonist L-655,708 \[[@B14],[@B15]\], while the δ-GABA~A~-Rs are typically insensitive to benzodiazepine \[[@B16],[@B17]\] but highly sensitive to THIP (gaboxadol) \[[@B18],[@B19]\].

Functional deficit of synaptic GABAergic inhibition plays an important role in the etiology of epilepsy \[[@B2],[@B20]-[@B22]\]. Recent studies revealed a possible role of tonic inhibition in modulating epileptic seizures \[[@B23],[@B24]\]. A significant reduction of GABA~A~-R α5 and δ subunit level has been reported in the hippocampus of animals with temporal lobe epilepsy (TLE) \[[@B8],[@B25],[@B26]\]. Interestingly, the decrease of δ subunit may be compensated by an increase of α4 and γ2 subunits \[[@B26]-[@B28]\]. Mutations in the δ subunit of GABA~A~-Rs have been mapped in human epilepsy patients \[[@B29],[@B30]\]. Increased δ subunit level during diestrus stage of ovarian cycle has been associated with less seizure activities in kainic acid-induced epilepsy models \[[@B31]\]. However, in the pyramidal neurons of hippocampal CA1 region, the α5 GABA~A~-R mediated tonic current was reduced but overall tonic inhibition was not changed or even increased in pilocarpine epilepsy model \[[@B32]\]. Furthermore, enhanced tonic inhibition in thalamocortical neurons was reported to induce absence seizure \[[@B33]\], suggesting that different tonic inhibition may play different roles in different brain regions.

Here we investigated the functional role of two distinctly different subtypes of extrasynaptic GABA~A~-Rs in hippocampal epileptogenesis. We demonstrated that enhancing tonic inhibition by overexpressing either the α5β3γ2 or α6β3δ extrasynaptic GABA~A~ receptors significantly inhibited the formation of epileptiform activity in hippocampal cultures. Furthermore, *in vivo* injection of selective extrasynaptic GABA~A~-R agonist THIP also inhibited epileptiform bursting activity in anesthetized rats and seizure behaviors in freely moving rats. Interestingly, low concentration of THIP did not affect basal level of neuronal activity, but significantly suppressed higher frequency neuronal firing. Therefore, our data suggest that tonic inhibition mediated by extrasynaptic GABA~A~-Rs may play a more prominent function in pathological conditions such as during epileptogenesis.

Results
=======

Molecular enhancement of tonic GABA currents after overexpressing α5β3γ2 GABA~A~ receptors
------------------------------------------------------------------------------------------

We have previously demonstrated that epileptiform activity downregulates tonic inhibition mediated by extrasynaptic GABA~A~ receptors \[[@B34]\]. In this study, we investigated the effect of enhanced tonic inhibition on epileptiform activity. The majority of extrasynaptic GABA~A~ receptors (GABA~A~-Rs) can be categorized into two distinct subtypes, containing either the α5 or the δ subunit. The α5-GABA~A~-Rs are mainly expressed in the hippocampus of adult brain, while δ-GABA~A~-Rs are mostly expressed in dentate and cerebellar granule cells as well as in the thalamus. To understand which subtype of extrasynaptic GABA~A~-Rs may affect epileptiform activity, we overexpressed both the α5β3γ2 and α6β3δ GABA~A~-Rs in hippocampal neurons to enhance tonic inhibition and tested their effects on epileptiform activity. Since α5 subunit is normally expressed in hippocampal pyramidal neurons \[[@B6]\], we first tested the effect of α5β3γ2 receptors on epileptiform activity. We have tested several α5 subunits and found a right one that can give large GABA-evoked current when coexpressed with the β3 and γ2 subunits in HEK 293T cells (Figure [1](#F1){ref-type="fig"}A). The inverse agonist L-655,708 (100 nM) specific for the α5 subunit significantly inhibited the GABA-evoked currents (Figure [1](#F1){ref-type="fig"}A-B; Control, 437 ± 63 pA, n = 10; L-655,708, 143 ± 26 pA, n = 10; \*\*\*, p \< 0.001; Student's *t* test), confirming that the GABA current was mediated by α5 subunit-containing GABA~A~-Rs. We next overexpressed the α5β3γ2 receptors in cultured hippocampal pyramidal neurons. The GABA-evoked whole-cell currents appeared to be similar between neurons transfected with the α5β3γ2 receptors and the mCherry for control (Figure [1](#F1){ref-type="fig"}C-D; mCherry, 3380 ± 408 pA, n =13; α5β3γ2, 3646 ± 518 pA, n = 14; p \> 0.5). However, tonic GABA currents revealed by acute application of GABA~A~-R blocker bicuculline (Bic, 40 μM; together with 1 μM TTX and 10 μM DNQX) \[[@B9],[@B34],[@B35]\], were significantly increased in α5β3γ2-transfected neurons compared to mCherry-transfected control neurons (Figure [1](#F1){ref-type="fig"}E-F; mCherry, 13.1 ± 1.7 pA, n = 8; α5β3γ2, 24.5 ± 4.2 pA, n = 8; p \< 0.05). These data demonstrated that overexpression of the α5β3γ2 receptors enhanced tonic GABA currents in hippocampal neurons.

![**Tonic GABA current increased after the overexpression of α5β3γ2 GABA**~**A**~**receptors. A**, Typical GABA (100 μM) induced currents in HEK293T cells transfected with α5β3γ2 subunits (left panel), which could be largely blocked by α5 subunit-specific inverse agonist L655,708 (100 nM, right panel). **B**, Summarized data showing GABA-induced α5β3γ2 receptor currents in HEK293T cells significantly inhibited by L655,708 (Control, 437.1 ± 63.1 pA, n = 10; L655,708, 142.8 ± 25.7 pA, n = 10; \*\*\*, p \< 0.001). **C**, Typical GABA current traces in cultured hippocampal neurons transfected with mCherry or plus the α5β3γ2 subunits. **D**, Bar graphs showing no significant difference between the total whole-cell GABA currents in neurons transfected with mCherry or plus the α5β3γ2 subunits. **E**, Representative tonic GABA currents revealed by rapid application of GABA~A~-R blocker bicuculline (100 μM) in hippocampal neurons transfected with mCherry or plus the α5β3γ2 subunits. **F**, Summarized data showing that tonic GABA current in α5β3γ2-transfected neurons (24.5 ± 4.2 pA, n = 8) was significantly increased in comparison with the control neurons (13.1 ± 1.7 pA, n = 8; \*, p \< 0.05).](1756-6606-6-21-1){#F1}

Tonic inhibition mediated by the α5β3γ2 receptors suppresses epileptiform activity
----------------------------------------------------------------------------------

We further tested whether epileptiform activity was affected by the enhanced tonic GABA current in neurons overexpressing the α5β3γ2 receptors. We previously established a unique cyclothiazide (CTZ) induced epilepsy model both *in vitro* and *in vivo*\[[@B36]-[@B39]\]. The advantage of CTZ model is its reliability in inducing epileptiform activity without significant cell death \[[@B36]\]. We treated hippocampal culture with CTZ (5 μΜ, 24 hr) to induce epileptiform activity, similar to reported before \[[@B36]\]. Control neurons transfected with mCherry showed robust epileptiform activity after CTZ-treatment, with a train of high-frequency action potentials overlaying on the plateau of large depolarization shifts (Figure [2](#F2){ref-type="fig"}A). In contrast, the majority of neurons transfected with the α5β3γ2 receptors did not show clear epileptiform activity, except some sparse action potentials on top of small depolarization bursts (Figure [2](#F2){ref-type="fig"}B). Quantitatively, about 90% of control neurons showed epileptiform activity after CTZ-treatment (26 out of 29 neurons), whereas only about 33% of neurons transfected with the α5β3γ2 receptors showed epileptiform activity (11 out of 33 neurons) (Figure [2](#F2){ref-type="fig"}C). The average frequency of epileptiform bursts was also significantly reduced in α5β3γ2-transfected neurons (Figure [2](#F2){ref-type="fig"}D; mCherry, 1.83 ± 0.35 per min, n = 29; α5β3γ2, 0.49 ± 0.16 per min, n = 33; p \< 0.001). Together, our experiments demonstrated that enhanced tonic inhibition mediated by the α5β3γ2 receptors significantly suppressed the formation of epileptiform activity in hippocampal neurons.

![**Inhibition of epileptiform activity in cultured hippocampal neurons overexpressing α5β3γ2 receptors. A**, Typical traces from two hippocampal neurons showing the epileptiform burst activity after chronic CTZ treatment (5 μΜ, 24 h). Panel b shows the expanded view of a single epileptiform burst from panel a. Epileptiform burst is characterized by a train of action potentials on a large depolarization shift. **B**, Representative traces showing the lack of epileptiform bursts in two hippocampal neurons transfected with the α5β3γ2 receptors. **C**, Bar graphs illustrating that overexpression of α5β3γ2 receptors significantly reduced the percentage of neurons showing epileptiform activity after chronic CTZ treatment (mCherry, \~90%, n = 29; α5β3γ2, \~33%, n = 33; \*\*\*, p \< 0.001). **D**, Neurons transfected with α5β3γ2 receptors showing lower burst frequency (0.49 ± 0.16 per min, n = 33), compared to mCherry controls after CTZ treatment (1.83 ± 0.35 per min, n = 29; \*\*\*, p \< 0.001).](1756-6606-6-21-2){#F2}

Inhibition of epileptiform activity by the α6β3δ receptors
----------------------------------------------------------

We next examined a distinctly different subtype of extrasynaptic GABA~A~-Rs, the α6β3δ receptors \[[@B11],[@B12]\], in the regulation of epileptiform activity. We first examined whole-cell GABA currents after overexpressing α6β3δ receptors in hippocampal cultures. GABA-evoked whole-cell currents showed no difference between GFP- and α6β3δ-transfected neurons (Figure [3](#F3){ref-type="fig"}A). Quantitatively, the average GABA-evoked current in α6β3δ-transfected neurons was 3327 ± 206 pA (n = 10), which was not significantly different from the GFP control (3967 ± 328 pA, n = 10, *p* \> 0.1; Figure [3](#F3){ref-type="fig"}B). To confirm functional expression of the α6β3δ receptors in hippocampal neurons, we examined tonic GABA current after Bic treatment and found that the tonic GABA current was greatly increased in α6β3δ-transfected neurons (Figure [3](#F3){ref-type="fig"}C). Quantitatively, the average amplitude of tonic GABA currents in α6β3δ-transfected neurons was 28.1 ± 3.6 pA (n = 10), significantly larger than that of control neurons (7.4 ± 1.1 pA, n = 11, *p* \< 0.0001) (Figure [3](#F3){ref-type="fig"}D). Furthermore, we employed THIP (5 μM), a relatively specific agonist for δ subunit containing GABA~A~-Rs at low concentration, to investigate tonic currents in control and α6β3δ-transfected neurons. THIP activated a small non-desensitizing tonic current in GFP-transfected neurons, accompanied with an increase of the baseline noise (Figure [3](#F3){ref-type="fig"}E, top trace). In α6β3δ-transfected neurons, however, the THIP-induced tonic current was markedly increased (Figure [3](#F3){ref-type="fig"}E, bottom trace). The average amplitude of THIP current in control neurons was 35.3 ± 7.4 pA (n = 11), and greatly increased to 962 ± 130 pA in α6β3δ-transfected neurons (n = 12, *p* \< 0.0001; Figure [3](#F3){ref-type="fig"}F). Thus, overexpression of α6β3δ receptors in hippocampal neurons significantly increased tonic GABA currents, similar to the overexpression of α5β3γ2 receptors.

![**Overexpression of α6β3δ subunits results in large tonic GABA current in cultured hippocampal neurons. A**, Typical recordings showing whole-cell currents induced by rapid application of GABA (20 μM) in GFP control and α6β3δ-transfected neurons in the presence of TTX (1 μM) and DNQX (10 μM). **B**, Summarized data showing no significant difference in whole-cell GABA currents between the two groups. **C**, Typical traces of tonic GABA currents, revealed by application of Bic (40 μM) in the presence of TTX (1 μM) and DNQX (10 μM), recorded from a GFP control neuron and a α6β3δ-transfected neuron. Holding potential = −70 mV. **D**, Summarized data showing that the average amplitude of tonic GABA currents was significantly increased in α6β3δ-transfected neurons (28.1 ± 3.6 pA, n = 10), compared to the GFP controls (7.4 ± 1.1 pA, n = 11; \*\*\*, *p* \< 0.0001). **E**, Tonic currents activated by THIP (5 μM) in GFP control and α6β3δ-transfected neurons. **F**, Summarized data showing a significant increase of THIP-induced tonic currents after transfection of α6β3δ subunits (962 ± 130 pA, n = 12), compared to the GFP controls (35.3 ± 7.4 pA, n = 11; \*\*\*, *p* \< 0.0001).](1756-6606-6-21-3){#F3}

We then examined whether overexpression of the α6β3δ receptors has any effect on epileptiform activity. In GFP-transfected control neurons, CTZ-treatment (5 μΜ, 24 hr) induced robust epileptiform activity as expected (Figure [4](#F4){ref-type="fig"}A). In contrast, hippocampal neurons transfected with α6β3δ receptors showed a significant attenuation of epileptiform activity (Figure [4](#F4){ref-type="fig"}B). Quantitatively, the percentage of neurons displaying epileptiform activity was 84% (21 out of 25) in GFP-transfected controls, but reduced to 31% (9 out of 29) in α6β3δ-transfected neurons (Figure [4](#F4){ref-type="fig"}C; *p* \< 0.001). Furthermore, the frequency of epileptiform bursts in α6β3δ-transfected neurons also reduced significantly (0.56 ± 0.2 bursts per min, n = 29, *p* \< 0.003), compared to that in GFP control neurons (1.64 ± 0.28 bursts per min, n = 25) (Figure [4](#F4){ref-type="fig"}D). We investigated whether the overexpression of extrasynaptic GABA~A~-Rs would alter neuronal intrinsic properties, but found no changes in resting membrane potential (mCherry, -52.3 ± 1.3 mV, n = 15; α5β3γ2, -50.1 ± 1.6 mV, n = 12; α6β3δ, -51.5 ± 1.4 mV, n = 10; p \> 0.5, one way ANOVA), membrane resistance (mCherry, 204 ± 22 MΩ, n = 15; α5β3γ2, 177 ± 17 MΩ, n = 12; α6β3δ, 237 ± 24 MΩ, n = 10; p \> 0.4), or membrane capacitance (mCherry, 96.3 ± 7.8 pF, n = 15; α5β3γ2, 114.6 ± 10.8 pF, n = 12; α6β3δ, 95.7 ± 16.1 pF, n = 10; p \> 0.19) in different transfected groups. Together, our data demonstrated that both α6β3δ and α5β3γ2 extrasynaptic GABA~A~-Rs have an important role in regulating hippocampal epileptogenesis *in vitro*.

![**Overexpression of α6β3δ receptors inhibits epileptiform bursting activity in cultured hippocampal neurons. Aa**, Representative traces showing the typical recurrent epileptiform bursts after chronic pretreatment with CTZ (5 μM, 24 h) in two different GFP-transfected pyramidal neurons. **Ab**, A single epileptiform burst in (**a**) was expanded to show a train of action potentials overlaying on a large depolarization shift. **Ba**, Representative traces showing the lack of typical epileptiform bursts in two α6β3δ-transfected hippocampal neurons. **Bb**, Expanded view of the boxed activity in (**a**). **C**, Bar graph showing the percentage of neurons with epileptiform bursting activity after chronic treatment with CTZ (5 μM for 24 h). \*\*\* *p* \< 0.001, Pearson Chi-Square test. **D**, Bar graph showing a significant reduction of the average epileptiform burst frequency in neurons transfected with α6β3δ receptors, comparing to GFP controls after CTZ treatment. \*\* *p* \< 0.01.](1756-6606-6-21-4){#F4}

Tonic inhibition on *in vivo* epileptic seizures
------------------------------------------------

After performing *in vitro* studies, we decided to further investigate the effect of tonic inhibition on epileptiform activity in *in vivo* condition. We recorded field potentials in the hippocampal CA1 pyramidal layer from 5 urethane-anaesthetized rats. In all 5 rats studied, the evoked responses following low frequency stimulation of CA3 region consisted of a large EPSP and a single population spike (PS) during control recordings (data not shown, see \[[@B36]\]), and the baseline activity was virtually 'silent' (Figure [5](#F5){ref-type="fig"}Aa). Following intra-cerebroventricular (i.c.v.) injection of CTZ (5 μmol in 5 μl), the single-peaked PS gradually transformed into a multiple-peaked event and the spontaneous recurrent epileptiform bursts were stable for at least 30 min in all 5 rats tested (Figure [5](#F5){ref-type="fig"}Ab). To enhance tonic inhibition *in vivo*, we chose to use agonist specific for extrasynaptic GABA~A~-Rs. For the α5 subunit-containing GABA~A~-Rs, there is no specific agonist available except inverse agonists that reduce receptor responses. However, THIP at low concentration is a selective agonist for the δ subunit-containing GABA~A~-Rs and widely used to elicit tonic inhibition both *in vitro* and *in vivo*\[[@B40]-[@B43]\]. Therefore, we delivered THIP (4 mg/kg) through the cannula pre-implanted in the lateral tail vein after the induction of epileptiform activity. Compared with the epileptiform burst number (7.2 ± 1.0 per 30 min) before THIP injection, the mean burst number after THIP administration was significantly reduced to 0.8 ± 0.4 (*p* \< 0.003) over a 30 min analysis period (Figure [5](#F5){ref-type="fig"}Ac). Interestingly, the inhibitory effect of THIP on epileptiform activity was reversible, as indicated by a gradual increase of the mean burst number (2.0 ± 0.7 per 30 min) during a prolonged recovery period after the THIP injection (Figure [5](#F5){ref-type="fig"}Ad). The quantification of the burst frequency of CTZ, CTZ + THIP, and the recovery group was summarized in Figure [5](#F5){ref-type="fig"}Ae. These results indicate that acute application of THIP in *in vivo* condition can effectively suppress epileptiform activity.

![**THIP inhibits CTZ-induced epileptiform activity and seizure behavior. Aa-d**, Typical traces showing 'silent' baseline activity of hippocampal CA1 neurons in control condition (**a**), synchronized epileptiform bursting activities induced by CTZ (5 μmol) (**b**), inhibition of THIP (4 mg /kg) on burst activity (**c**), and the recovery after the THIP injection (**d**). A**e**, Bar histogram showing group data of THIP inhibition on CTZ-induced epileptiform burst activities. **B**, Bar histogram showing group data of CTZ-induced (5 μmol) seizure behavioral score and its significant attenuation by pre-treatment with THIP (10 mg/kg). THIP(5): 5 mg/kg THIP; THIP(10): 10 mg/kg THIP. \* *p* \< 0.05 and \*\* *p* \< 0.01 in comparison with CTZ injection alone; \# *p* \< 0.05 for recovery, in comparison with CTZ + THIP.](1756-6606-6-21-5){#F5}

Besides epileptiform activity, we further studied whether THIP can directly modulate CTZ-induced seizure behavior in freely moving rats \[[@B38]\]. CTZ was injected repeatedly each day (0.25 μmol i.c.v. for 3 consecutive days, total dose of 0.75 μmol) to induce seizure behavior without or with a pre-injection of THIP. The administration of THIP (5 or 10 mg/kg, i.p.) at 10 min before CTZ injection dose-dependently attenuated the convulsant seizures induced by CTZ. The seizure score was 4.5 ± 0.3 (n = 6) after CTZ injection alone, and significantly reduced to 2.6 ± 0.7 (n = 7) in THIP-preinjected (10 mg/kg) animals (*p* \< 0.05; Figure [5](#F5){ref-type="fig"}B). The lower dose of THIP pretreatment (5 mg/kg) also reduced seizure score but not reaching statistical significance. Therefore, THIP may be used as a potential anticonvulsant drug to suppress seizure behaviors in living animals.

Tonic inhibition and basal GABAergic neurotransmission
------------------------------------------------------

While previous studies have linked tonic inhibition with seizure threshold \[[@B31],[@B44]\], the underlying mechanism is not fully understood. We decided to investigate the mechanism of tonic inhibition in regulating epileptiform activity. One question we addressed is whether tonic inhibition has any direct effect on basal GABAergic synaptic transmission in rat hippocampal cultures. Spontaneous miniature inhibitory postsynaptic currents (mIPSCs) were recorded in the presence of TTX (1 μM) and CNQX (10 μM) to block action potentials and glutamatergic responses, respectively. We have previously shown that THIP at micromolar concentrations elicited a tonic current (10--30 pA) in hippocampal neurons \[[@B34]\]. Here, we found that application of 5 μM THIP had no significant effect on both the mIPSC amplitude (control, 18.9 ± 1.1 pA, n = 12; THIP, 18.3 ± 1.3 pA, n = 12; p \> 0.6) and the frequency (control, 0.76 ± 0.18 Hz, n = 12; THIP, 0.96 ± 0.30 Hz, n = 12; p \> 0.4) (Figure [6](#F6){ref-type="fig"}). We did notice that the baseline noise in the presence of THIP was always larger than the controls, indicating the tonic activation of extrasynaptic GABA~A~-Rs by low concentration of THIP. The null effect of 5 μM THIP on mIPSCs suggested that synaptic GABA~A~-Rs are not significantly affected at this low concentration of THIP.

![**THIP at low concentration has no effect on the amplitude and frequency of mIPSCs. A**, **B**, Representative traces showing mIPSCs recorded in control and THIP (5 μM) treated neurons. Note that in the presence of THIP, baseline was always noisier than control traces, indicating the activation of extrasynaptic GABA~A~-Rs. **C**, **D**, No significant difference between the mIPSC amplitude (*p* \> 0.6) and frequency (*p* \> 0.4) in control and THIP-treated neurons.](1756-6606-6-21-6){#F6}

Mechanism of tonic inhibition in modulating neuronal activity
-------------------------------------------------------------

We next examined the effect of THIP on neuronal activity at basal level as well as under stimulated conditions. In normal bathing solution, application of low concentration of THIP (5 μM) showed no significant effect on action potential firing in the majority of neurons tested (Figure [7](#F7){ref-type="fig"}A-B; control, 0.055 ± 0.015 Hz; THIP, 0.050 ± 0.013 Hz; n = 12, *p* \> 0.4, paired *t* test). However, when neuronal activity was elevated by CTZ (5 μM) as demonstrated previously \[[@B36]\], THIP exerted a significant inhibitory effect on neuronal activity (Figure [7](#F7){ref-type="fig"}C-D). Action potential firing frequency dropped significantly from 0.152 ± 0.027 Hz under CTZ application to 0.092 ± 0.022 Hz when THIP was applied together with CTZ (n = 17, *p* \< 0.01, paired *t* test). To confirm that THIP has greater effect when neuronal activity is elevated, we further stimulated neurons with low concentration of kainic acid (KA). Bath application of KA (2.5 μM) induced a large membrane depolarization and a remarkable increase of action potential firing (Figure [7](#F7){ref-type="fig"}E). Importantly, co-application of 5 μM THIP together with KA significantly decreased the firing frequency in all of the neurons recorded (Figure [7](#F7){ref-type="fig"}E-F; KA, 1.4 ± 0.4 Hz; KA+THIP, 0.6 ± 0.1 Hz; n = 10, *p* \< 0.03, paired *t* test). Together, our results suggest that tonic inhibition may have greater modulatory effect on neural networks with hyperexcitatory activity, such as that under epileptogenic stimulation, making extrasynaptic GABA~A~-Rs ideal for developing novel anti-convulsant drugs.

![**THIP effect on basal and elevated neuronal activity. A**, **B**, THIP had no significant effect on the basal level of action potential firing (*p* \> 0.4, n = 12). **C**, **D**, THIP significantly inhibited CTZ-induced action potentials (*p* \< 0.01, n = 17). **E**, **F**, THIP also inhibited KA-induced action potentials (*p* \< 0.03, n = 10).](1756-6606-6-21-7){#F7}

Discussion
==========

In this study, we have demonstrated that two distinct subtypes of extrasynaptic GABA~A~-Rs both play an important role in regulating the formation of epileptiform activity in hippocampal cultures. Enhancing tonic inhibition in living animals *in vivo* also modulates epileptiform activity and behavioral seizures in a dose-dependent manner. More importantly, we demonstrated that tonic inhibition potently inhibits high frequency action potentials under stimulated conditions but not at basal low frequency firing condition, suggesting a novel mechanism of tonic inhibition in regulating neural network activity.

Extrasynaptic GABA~A~-Rs regulate epileptogenesis
-------------------------------------------------

Due to its continuous activation by ambient GABA, the charge transfer of tonic currents mediated by extrasynaptic GABA~A~-Rs have been estimated to be several folds more than phasic currents mediated by synaptic GABA~A~-Rs \[[@B4],[@B45],[@B46]\]. Tonic GABA conductance controls the overall gain of neuronal input--output \[[@B5],[@B45]-[@B48]\]. Therefore, when GABA~A~ receptor α5 and δ subunits were found significantly reduced in the hippocampus of animal TLE models \[[@B8],[@B25],[@B49],[@B50]\], it was realized that downregulation of tonic inhibition might have contributed to epileptogenesis. Consistently, our previous work has also demonstrated that tonic GABA inhibition was downregulated after chronic epileptogenic stimulation in cultured hippocampal neurons \[[@B34]\]. However, later studies found that despite a reduction of α5 and δ subunit expression in epileptic mice, tonic inhibition in the hippocampus was largely maintained or even increased, possibly mediated by increased expression of α4γ2-containing GABA~A~-Rs \[[@B26],[@B28],[@B32]\]. Thus, tonic inhibition might have undergone homeostatic changes during and after epileptogenesis \[[@B51]\]. Our current study demonstrated that enhancing tonic inhibition by increasing the expression level of either α5β3γ2 or α6β3δ receptors can effectively suppress epileptiform activity. We have further demonstrated that seizure behaviors are attenuated by enhancing tonic inhibition *in vivo*. Based on previous and our own studies, we attribute an important role to tonic inhibition in modulating hippocampal epileptogenesis: enhancing tonic inhibition will inhibit epileptiform activity, while reducing tonic inhibition will increase the susceptibility of epileptic seizures \[[@B31],[@B44]\].

Overexpression of extrasynaptic GABA~A~-Rs regulates epileptiform activity
--------------------------------------------------------------------------

While THIP has been used previously to modulate epileptiform activity, the target receptors were usually not specifically identified because higher concentrations of THIP might activate different combinations of synaptic and extrasynaptic GABA~A~-Rs. Our current study provides more direct evidence on extrasynaptic regulation of epileptogenesis by demonstrating that overexpression of both α5β3γ2 and α6β3δ receptors can effectively attenuate epileptiform activity. We showed that neurons transfected with both α5β3γ2 and α6β3δ receptors had enhanced tonic currents compared to control neurons. Mutations in the δ subunit of GABA~A~ receptors have been mapped in human epilepsy patients \[[@B29],[@B30]\], indicating the clinical relevance of δ-GABA~A~ receptors. Our molecular expression studies suggest that extrasynaptic GABA~A~-Rs may be a potential therapeutic target for developing antiepileptic drugs to treat TLE.

THIP regulation of neuronal activity
------------------------------------

Previous studies have reported that THIP may inhibit neuronal activity \[[@B52]-[@B56]\]. However, these studies used concentrations much higher than our current work. It is known that high concentration of THIP may directly activate γ2-containing synaptic GABA~A~-Rs \[[@B42],[@B57],[@B58]\]. In this study, we used a low concentration of THIP (5 μM) that did not affect mIPSCs, indicating that at this concentration THIP did not activate synaptic GABA~A~-Rs. Correspondingly, we found that 5 μM THIP did not affect basal neuronal firing in the majority of neurons tested. More importantly, we discovered a strong inhibitory effect of THIP on elevated neuronal activity induced by both CTZ and KA. It is possible that elevated neuronal activity may induce substantial release of GABA \[[@B46]\], which will act together with THIP to enhance tonic inhibition and reduce neuronal activity. Another possibility is that tonic current may be outward rectifying at depolarized membrane potential \[[@B59]\], making the effect of THIP more potent when neurons are hyperexcitatory. Our discovery of the preferential inhibition of THIP on elevated activity makes it an ideal candidate for anticonvulsant drug, because it may have less side effects comparing to those affecting basal neural activity.

Conclusions
===========

We employed both molecular and pharmacological tools to demonstrate that tonic inhibition modulates epileptiform activity both *in vitro* and *in vivo*. The overexpression of both α5β3γ2 and α6β3δ receptors inhibited the formation of epileptiform activity in hippocampal neurons, establishing unambiguously a solid ground for extrasynaptic modulation of epileptogenesis. Furthermore, we discovered a more prominent role of tonic inhibition in inhibiting hyperexcitatory activity rather than low frequency basal activity, suggesting that extrasynaptic GABA~A~-Rs are ideal drug targets for developing anti-convulsant drugs that may specifically act against epileptiform activity without much side effect on normal brain functions.

Methods
=======

Primary neuronal culture
------------------------

Primary hippocampal neurons were prepared from embryonic day 18 Sprague--Dawley rat embryos of either sex, similar to our previous work with modifications \[[@B34]\]. Briefly, after dissection of the hippocampi, the tissue was rinsed in cold HBS and then digested with 0.05% trypsin-EDTA for 20 min at 37°C, followed by trituration with pipettes in the plating medium (DMEM with 10% FBS and 10% F12). After rinsing for twice, cells were counted and plated onto coverslips precoated with 0.1 mg/ml poly-D-lysine (Sigma). After culturing for 1 day, media were changed into neuronal culture media (neurobasal media containing 2 mM GlutaMAX™-I Supplement and 2% B-27). AraC (1 μM, Sigma) was added 6--8 days after plating, and cells were fed twice weekly thereafter and maintained at 37°C and in 5% CO~2~ incubators. Trypsin-EDTA, DMEM, FBS, F12, Neurobasal media, GlutaMAX™-I Supplement and B-27 were purchased from Invitrogen Corporation. Some experiments were also performed using mouse hippocampal cultures.

DNA transfection
----------------

Calcium-phosphate transfection was performed similar to the protocol previously described \[[@B60]\]. Neurons were transfected at 10 days *in vitro* (DIV). The plasmids of rat α5, α6, β3, γ2, δ subunits of GABA~A~ receptors (gifts from Drs. Robert Macdonald, Matthias Kneussel, and Dr. Bernhard Luscher) were co-transfected with pEGFP or mCherry (Clontech). Transfection with EGFP or mCherry alone served as controls. Most of the experiments were performed around 2 weeks of culture unless otherwise indicated.

Electrophysiological recordings in cultured hippocampal neurons
---------------------------------------------------------------

Whole-cell recordings were performed in current- or voltage-clamp mode using a MultiClamp 700B amplifier (Axon Instruments). Patch pipettes were pulled from borosilicate glass (Sutter Instrument, BF150-86-10) and fire polished (4--6 MΩ). The recording chamber was continuously perfused with a bath solution consisting of (mM): 128 NaCl, 30 Glucose, 25 Hepes, 5 KCl, 2 CaCl~2~, 1 MgCl~2~, pH 7.3 adjusted with NaOH. The pipette solution for recording action potentials and mEPSCs contained (mM): 125 K-gluconate, 10 KCl, 5 EGTA, 10 Hepes, 10 Tris-phosphocreatine, 4 MgATP, 0.5 NaGTP, pH 7.3 adjusted with KOH. For tonic GABA currents and GABA-induced whole-cell currents, patch pipettes were filled with (mM): 135 KCl, 10 Tris-phosphocreatine, 2 EGTA, 10 Hepes, 4 MgATP, 0.5 NaGTP, pH 7.3 adjusted with KOH. Liquid junction potentials were always corrected before forming giga-ohm seal. The series resistance was typically 10--20 MΩ and partially compensated by 30-50%. Data were acquired using pClamp 10.2 software (Axon Instruments), sampled at 2--10 kHz, and filtered at 1 kHz. Off-line analysis was done with Clampfit 10.2 software (Axon Instruments). Miniature events were analyzed using Mini Analysis software (Synaptosoft). Large depolarization shift resembling paroxysmal depolarization shift is defined here as ≥ 10 mV depolarization and ≥ 300 ms in duration. An epileptiform burst is defined by at least five consecutive action potentials overlaying on top of the large depolarization shift. When quantifying the percentage of neurons showing epileptiform activity, the criterion is at least two epileptiform bursts occurring during 10 min of recording. All of the drugs used were freshly diluted in bath solution to their final concentrations before experiments.

Electrophysiological recordings in anaesthetized rats
-----------------------------------------------------

Adult male Sprague--Dawley rats weighing between 250--350 g were maintained on an *ad libitum* feeding schedule and kept on a 12 hr on/off light cycle. During electrophysiological study, rats were anesthetized with urethane (1.2 g/kg, i.p.) and the level of anesthesia was assessed by the absence of a withdrawal reflex, and additional anesthetic (urethane, 0.2-0.6 mg/kg, i.p.) was administered as necessary. Body temperature was maintained at 37 ± 0.5°C with a Harvard Homoeothermic Blanket (Harvard Apparatus Limited, Kent, UK). At the end of experiments, animals were killed with an overdose of urethane. All animal experiments were approved by the local committee of Laboratory Animals, Fudan University and carried out in accordance with Chinese National Science Foundation animal research regulation. Animal preparation was similar to previously reported \[[@B36],[@B37],[@B39]\]. Briefly, all the animals had their lateral tail vein cannulated for drug administration and then mounted in a stereotaxic frame. An incision was made in the midline of the head to expose the top part of the skull for the implantation of i.c.v. guide cannula (22GA, Plastics One, USA) into the lateral ventricle (0.3 mm posterior to bregma, 1.3 mm lateral to the midline, and 4 mm below the skull surface), and then secured by the dental cement. For recording and stimulating, a large burr hole was made in the left side of the incised skull above the hippocampal area, and the dura was pierced and removed. A concentric bipolar stimulating electrode (Harvard Apparatus) was placed close to the CA3 region (3.8-4.5 mm posterior to bregma, 3.5-4.0 mm lateral to the midline, and 3.0-3.8 mm below the brain surface) in order to stimulate the Shaffer collateral pathway. For recording in the CA1 pyramidal cell layer, a tungsten electrode (0.5 MΩ, WPI, USA) was placed 3.5-4.2 mm posterior to bregma, 2.0-3.0 mm lateral to the midline. The depth of the recording electrode was approximately 2.0-2.5 mm below the brain surface as determined by the sudden change of electrical noise and the shape of the evoked field excitatory postsynaptic potentials (fEPSPs) and population spike (PS). For stimulation, a constant current generator passed a square-wave pulse (0.2 ms in duration) through the stimulating electrode (test pulse) and the stimulation frequency was set at once per minute. The electrophysiological signals were amplified and filtered (0.3-3 kHz) using a NeuroLog System (Digitimer Ltd., Hearts, UK) and visualized and stored in a PC computer through an A-D converter, CED 1401 micro (Cambridge Electronic Design, Cambridge, UK). After both electrodes were in the right place, the fEPSPs and PS were monitored for at least 30 min until a stable recording was achieved. Following a 30 min baseline recording, CTZ (5 μmol, 5 μL) was administered i.c.v. via the pre-implanted guide cannula into the left lateral ventricle. Pharmacologically induced seizure-like activity was monitored after CTZ injection by observing the change of the evoked potentials transforming from single PS into a multi-peaked display, and spontaneous seizure burst activity in CA1 pyramidal neurons \[[@B37],[@B39],[@B61]\]. After the epileptiform burst activity was stable for at least 30 min, THIP (4 mg/kg in 1 mL/kg) or vehicles were delivered through the cannula pre-implanted in the lateral tail vein. To confirm correct placement of the electrode and cannula, the brain was taken for histological validation of the injection and recording/stimulating sites. Epileptiform activity within CA1 pyramidal cells was analyzed offline using Spike2 software (an analyzing program for CED 1401, Cambridge Electronics, UK) and specific scripts designed for this study with Spike2. The highly synchronized bursting activity was defined as having high frequency multiple high amplitude spikes (\>0.5 mV) with an initial interspike interval of less than 0.1 s, a minimum of 5 spikes, and burst duration over 1 s \[[@B37]\].

Behavioral test in freely moving rats
-------------------------------------

CTZ induced seizure behavioral test was carried out similarly as previously reported \[[@B38]\]. Briefly, under general anesthetics with sodium pentobarbital (60 mg/kg, i.p.), a guide cannula was pre-implanted into left lateral ventricle (0.3 mm posterior to bregma, 1.3 mm lateral to the midline, and 4 mm below the skull surface) at least 5 days before the behavioral test. Cannula-implanted animals were randomly divided into following experimental groups: 1) CTZ group: 0.25 μmol (i.c.v.) for one injection per day, three consecutive days; 2) THIP + CTZ group one: 5 mg/kg (i.p.) THIP + 0.25 μmol (i.c.v.) CTZ for one injection per day, three consecutive days; 3) THIP + CTZ group two: 10 mg/kg (i.p.) THIP + 0.25 μmol (i.c.v.) CTZ for one injection per day, three consecutive days. All behavioral tests were carried out between 2:00 pm and 7:00 pm. The animals were first placed in a plastic cage and acclimatized for at least half an hour before experiments. Before and after drug injection, animal behavior was continuously monitored for a period of 1 and 3 hours with video recording, respectively. Behavioral seizures were scored using 5-graded Racine Score system \[[@B62]\]. Briefly, Racine score I, facial clonus; score II, head nodding; score III, unilateral forelimb clonus; score IV, rearing with bilateral forelimb clonus; score V, rearing and falling (loss of postural control).

Data analysis
-------------

Group data were expressed as mean ± SEM. Across different groups of data, statistical significance between means was determined using one-way ANOVA with Tukey HSD post hoc analysis. Comparison within a group used a paired or unpaired *t* test (GraphPad Prism, GraphPad Software Inc.). Pearson Chi-Square test was used for statistical analysis of percentage (SPSS). Significance level was set at *p* \< 0.05.

Drugs and solutions
-------------------

Cyclothiazide (CTZ) and L655708 were purchased from Tocris (Northpoint, Bristol). THIP (4,5,6,7-tetrahydroisoxazolo\[4,5-c\] pyridine-3-ol and urethane (25% in distilled water) were purchased from Sigma Aldrich Chemical Co. (Poole, Dorset).
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